Lomefloxacin
From Wikipedia, the free encyclopedia
|
Lomefloxacin
|
|
| Systematic (IUPAC) name | |
| 1-ethyl-6,8-difluoro- 7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3- carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | J01 S01AX17 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H19F2N3O3 |
| Mol. mass | 351.348 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 10% |
| Metabolism | ? |
| Half life | 8 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Lomefloxacin hydrochloride (Maxaquin) is a fluoroquinolone antibiotic, used to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery. It is taken orally, usually daily for 10-14 days.
Lomefloxacin is unique in that it forms a magnesium chelate with itself. The chelate is formed between the 2-carbonyl group of two separate lomefloxacin molecules.
|
|||||||||||

